Skip to Main Content

Paper Details

Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial.
Am Heart J
15
2021
Author NameAffiliation
Renato D LopesDuke Clinical Research Institute, Duke University Medical Center, NC Brazilian Clinical Research Institute
John H AlexanderDuke Clinical Research Institute, Duke University Medical Center
  • 1 - 2

Datasets

Release 1.2